New diabetes shot tested for better blood sugar control
NCT ID NCT06849843
Summary
This study tested a new injectable medication called Efsubaglutide Alfa for people with type 2 diabetes whose blood sugar was still too high despite diet and exercise. It involved 59 participants and compared two different dosing schedules—one shot every two weeks versus one shot every week—over 12 weeks to see which was better at lowering long-term blood sugar levels (HbA1c). The main goal was to see if the less frequent injection worked as well as the weekly one.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CangZhou Hospital of Integrated TCM and Western Medicine in Hebei Province
Cangzhou, China
-
Huzhou Central Hospital
Huzhou, China
-
Jiangsu Province Offical Hospital
Nanjing, China
-
Nanjing First Hospital
Nanjing, Jiangsu, 210008, China
-
Ningbo First Hospital
Ningbo, China
-
Ningbo Medical Center Lihuili Hospital
Ningbo, China
-
The First Affiliated Hospital of Soochow University
Suzhou, China
-
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
-
Wenzhou Central Hospital
Wenzhou, China
-
Zibo Municipal Hospital
Zibo, China
Conditions
Explore the condition pages connected to this study.